Literature DB >> 10573244

Lung function after bilateral lower lobe lung volume reduction surgery for alpha1-antitrypsin emphysema.

A F Gelb1, R J McKenna, M Brenner, R Fischel, N Zamel.   

Abstract

This study explores the mechanism(s) of airflow limitation following lung volume reduction surgery (LVRS) in patients with emphysema due to homozygous alpha1-antitrypsin (AT) deficiency. Bilateral targeted lower lobe stapled LVRS using video thoracoscopy was performed in six patients (five males) aged 61+/-9 yrs (mean+/-SD) with alpha1-AT emphysema. Two patients received only a 6-month follow-up. However, four patients, at 22, 24, 27 and 36 months post-LVRS, noted relief from dyspnoea and increased walk tolerance. At 27+/-6 months (mean+/-SD) post-LVRS, their forced expiratory volume in one second improved only from 30+/-2% of the predicted value (mean+/-SEM) before surgery to 33+/-1% pred after surgery. Yet, total lung capacity (TLC) decreased from 151+/-13 to 127+/-10% pred; diffusing capacity increased from 35+/-9 to 59+/-9% pred; and vital capacity increased from 68+/-10 to 88+/-5% pred. In three patients, static lung elastic recoil at TLC increased from 1.1+/-0.15 to 1.2+/-0.10 kPa. Using flow/pressure curves, the mechanism for expiratory airflow limitation pre-LVRS and the improvement noted post-LVRS could be primarily accounted for by the initial loss and subsequent increase in lung elastic recoil. Bilateral lung volume reduction surgery provides modest physiologic improvement for 2-3 yrs in patients with alpha1-antitrypsin emphysema due to increases in lung elastic recoil.

Entities:  

Mesh:

Year:  1999        PMID: 10573244     DOI: 10.1034/j.1399-3003.1999.14d33.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Selection of patients for lung volume reduction surgery using a power law analysis of the computed tomographic scan.

Authors:  H O Coxson; K P Whittall; Y Nakano; R M Rogers; F C Sciurba; R J Keenan; J C Hogg
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

Review 2.  Bronchoscopic lung volume reduction in severe emphysema.

Authors:  Edward P Ingenito; Douglas E Wood; James P Utz
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 3.  National Emphysema Treatment Trial state of the art: genetics of emphysema.

Authors:  Craig P Hersh; Dawn L DeMeo; Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

4.  Low cost biological lung volume reduction therapy for advanced emphysema.

Authors:  Mostafa Bakeer; Taha Taha Abdelgawad; Raed El-Metwaly; Ahmed El-Morsi; Mohammad Khairy El-Badrawy; Solafa El-Sharawy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-08-03

Review 5.  Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.

Authors:  Jack Dummer; Claudia C Dobler; Mark Holmes; Daniel Chambers; Ian A Yang; Lianne Parkin; Sheree Smith; Peter Wark; Anouk Dev; Sandra Hodge; Eli Dabscheck; Julian Gooi; Sameh Samuel; Steven Knowles; Anne E Holland
Journal:  Respirology       Date:  2020-02-06       Impact factor: 6.424

6.  Functional results of unilateral lung volume reduction surgery in alpha1-antitrypsin deficient patients.

Authors:  Gaëlle Dauriat; Hervé Mal; Gilles Jebrak; Olivier Brugière; Yves Castier; Juliette Camuset; Armelle Marceau; Camille Taillé; Guy Lesèche; Michel Fournier
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

7.  Physiological modeling of responses to upper versus lower lobe lung volume reduction in homogeneous emphysema.

Authors:  Arschang Valipour; Mordechai R Kramer; Franz Stanzel; Axel Kempa; Sherwin Asadi; Oren Fruchter; Ralf Eberhardt; Felix J Herth; Edward P Ingenito
Journal:  Front Physiol       Date:  2012-10-01       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.